
Ara Dickran Metjian
Associate Professor of Medicine · Duke Department of Medicine
Credentials: · · ·
History
- Present
Duke Department of Medicine
- 2001
Hahneman Medical College of the Pacific
Research
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
New England Journal of Medicine · 2019 · 788 citations
Molecular and Cellular Biology · 1998 · 165 citations
Blood Advances · 2021 · 67 citations

8 papers
- SC
6 papers

5 papers

5 papers

4 papers
- BG
4 papers · 3 as a fellow

4 papers

4 papers
Grants
- 2011–2015
Public Health Surveillance of Bleeding Disorders Outside Htcs
NCBDDD · U27
Contact PI · $780K · Duke University
Clinical trials
- 2025–2029
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Site PI · Recruiting · Phase 3
Takeda
- 2025–2028
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Site PI · Recruiting · Phase 3
Takeda



